Keyphrases
Arterial Thromboembolism
100%
Blood Control
9%
Cancer Targeting
9%
Cancer Types
9%
Cancer-specific
9%
Cause-specific
9%
Clinical Covariates
9%
Coronary Revascularization
9%
Cox Proportional Hazards Regression
9%
Electronic Medical Records
9%
Genetic Modification
27%
Genetic Profile
100%
High-risk Population
9%
Impact of Cancer
9%
Ischemic Stroke
9%
KRAS Oncogene
9%
Limb Revascularization
9%
Memorials
9%
Metastatic Disease
9%
Mutation Profiling
9%
Myocardial Infarction
9%
Patients with Cancer
9%
Peripheral Arterial Occlusion
9%
Retrospective Cohort Study
9%
Solid Cancer
100%
Solid Tumors
9%
STK11
18%
Target Validation
9%
Thromboembolic Risk
100%
Tumor Genetics
9%
Tumor Genomics
100%
Tumor Profiling
9%
Tumor Subtype
9%
Tumor Suppressor Gene
9%
Biochemistry, Genetics and Molecular Biology
Cohort Study
50%
Electronic Medical Record
50%
Gene Mutation
50%
High Risk Population
50%
KRAS
100%
Oncogene
50%
STK11
100%
Tumor Suppressor Gene
50%
Medicine and Dentistry
Arterial Thromboembolism
100%
Artery Occlusion
9%
Brain Ischemia
9%
Cancer Types
9%
Electronic Patient Record
9%
Gene Mutation
9%
Heart Muscle Revascularization
9%
High Risk Population
9%
Limb
9%
Malignant Neoplasm
100%
Metastatic Carcinoma
9%
Myocardial Infarction
9%
Neoplasm
100%
Oncogene
9%
Proportional Hazards Model
9%
Retrospective Cohort Study
9%
Revascularization
9%
Solid Malignant Neoplasm
9%
Somatics
9%
Tumor Suppressor Gene
9%
Pharmacology, Toxicology and Pharmaceutical Science
Arterial Thromboembolism
100%
Artery Occlusion
9%
Brain Ischemia
9%
Cohort Study
9%
Heart Infarction
9%
Malignant Neoplasm
100%
Metastasis
9%
Neoplasm
100%
Solid Malignant Neoplasm
9%
Tumor Suppressor Protein
9%